📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Real-World Severe COVID-19 Outcomes Associated with Use of Antivirals and Neutralising Monoclonal Antibodies: A Population-Based Retrospective Cohort Study in Scotland (2023)

First Author: Tibble H

Attributed to: Phase 1 COVID-19 Data and Connectivity – National Core Study (Phase 1 D&C-NCS) funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.2139/ssrn.4356763

Publication URI: http://dx.doi.org/10.2139/ssrn.4356763

Type: Preprint